Literature DB >> 34306323

The role of autophagy in hepatic fibrosis.

Mei Sun1, Li Tan1, Min Hu1.   

Abstract

Hepatic fibrosis is a chronic liver injury process, and its continuous development can lead to cirrhosis, hepatic failure and even hepatocellular carcinoma (HCC). Autophagy has attracted much attention because of its controversial role in the course of hepatic fibrosis. In this review, we introduce the mechanism related to noncoding RNAs and some of the signaling pathways that promote or inhibit fibrosis by affecting autophagy. Finally, we list some targets related to autophagy that enable hepatic fibrosis therapy and forecast its prospect in hepatic fibrosis. This review will provide new ideas in diagnosing and treating hepatic fibrosis, which will be helpful to reduce the incidence of cirrhosis and its complications. AJTR
Copyright © 2021.

Entities:  

Keywords:  Hepatic fibrosis; autophagy; exosomes; hepatic stellate cell; noncoding RNA

Year:  2021        PMID: 34306323      PMCID: PMC8290830     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  75 in total

1.  Gα12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells.

Authors:  Kyu Min Kim; Chang Yeob Han; Ji Young Kim; Sam Seok Cho; Yun Seok Kim; Ja Hyun Koo; Jung Min Lee; Sung Chul Lim; Keon Wook Kang; Jae-Sung Kim; Se Jin Hwang; Sung Hwan Ki; Sang Geon Kim
Journal:  J Hepatol       Date:  2018-01-02       Impact factor: 25.083

2.  ANG II promotes autophagy in podocytes.

Authors:  Anju Yadav; Sridevi Vallabu; Shitij Arora; Pranay Tandon; Divya Slahan; Saul Teichberg; Pravin C Singhal
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-19       Impact factor: 4.249

3.  MicroRNA-125a/VDR axis impaired autophagic flux and contributed to fibrosis in a CCL4-induced mouse model and patients with liver cirrhosis.

Authors:  Wei He; Weijie Ni; Lili Zhao; Xiang Wang; Li Liu; Zhining Fan
Journal:  Life Sci       Date:  2020-10-29       Impact factor: 5.037

Review 4.  The role of nuclear factor kappa B (NF-κB) in filarial pathology.

Authors:  Fatima Amponsah Fordjour; Ebenezer Asiedu; Amma Larbi; Alexander Kwarteng
Journal:  J Cell Commun Signal       Date:  2021-02-25       Impact factor: 5.908

5.  Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.

Authors:  Swati Dhar; Avinash Kumar; Agnes M Rimando; Xu Zhang; Anait S Levenson
Journal:  Oncotarget       Date:  2015-09-29

6.  GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition.

Authors:  Eloïne Bestion; Zuzana Macek Jilkova; Jean-Louis Mège; Marie Novello; Keerthi Kurma; Seyedeh Tayebeh Ahmad Pour; Gilles Lalmanach; Lise Vanderlynden; Lionel Fizanne; Firas Bassissi; Madani Rachid; Jennifer Tracz; Jérôme Boursier; Jérôme Courcambeck; Cindy Serdjebi; Christelle Ansaldi; Thomas Decaens; Philippe Halfon; Sonia Brun
Journal:  Ther Adv Chronic Dis       Date:  2020-07-16       Impact factor: 5.091

7.  Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape.

Authors:  Agata Page; Pier Paoli; Eva Moran Salvador; Steve White; Jeremy French; Jelena Mann
Journal:  J Hepatol       Date:  2015-11-26       Impact factor: 25.083

8.  LncRNA-SNHG7/miR-29b/DNMT3A axis affects activation, autophagy and proliferation of hepatic stellate cells in liver fibrosis.

Authors:  Zhengyuan Xie; Yuanhao Wu; Sifu Liu; Yueliang Lai; Shenglan Tang
Journal:  Clin Res Hepatol Gastroenterol       Date:  2020-09-04       Impact factor: 2.947

9.  Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression.

Authors:  Nicola Coppola; Nicoletta Potenza; Mariantonietta Pisaturo; Nicola Mosca; Gilda Tonziello; Giuseppe Signoriello; Vincenzo Messina; Caterina Sagnelli; Aniello Russo; Evangelista Sagnelli
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

10.  MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.

Authors:  Jianliang Chen; Yue Yu; Shu Li; Yuting Liu; Shu Zhou; Shouji Cao; Jie Yin; Guoqiang Li
Journal:  J Cell Mol Med       Date:  2017-08-01       Impact factor: 5.310

View more
  3 in total

Review 1.  ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets.

Authors:  Caroline C Duwaerts; Jessica L Maiers
Journal:  Front Mol Biosci       Date:  2022-01-31

Review 2.  Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios.

Authors:  Swati Katoch; Vinesh Sharma; Vikram Patial
Journal:  World J Gastroenterol       Date:  2022-07-28       Impact factor: 5.374

Review 3.  Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis.

Authors:  Wen-Qing Li; Wen-Hao Liu; Die Qian; Jia Liu; Shi-Qiong Zhou; Lei Zhang; Wei Peng; Li Su; Hong Zhang
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.